These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2412276)

  • 1. Inhibition of DNA and RNA synthesis in rat liver nuclei by oncogenic and non-oncogenic beta-blockers.
    Riboni L; Presta M; Ziliani S; Mazzocchi C; Braga G; Mazzoleni G; Ragnotti G
    Toxicol Pathol; 1985; 13(1):18-25. PubMed ID: 2412276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo DNA damage of male and female rat liver nuclei by oncogenic and nononcogenic beta blockers.
    Presta M; Mazzocchi C; Ziliani S; Ragnotti G
    J Natl Cancer Inst; 1983 Apr; 70(4):747-52. PubMed ID: 6132020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical isomers of the hepatocarcinogenic beta-blocker ZAMI 1305: influence on nucleic acids synthesis and DNA integrity.
    Mazzocchi C; Presta M; Ziliani S; Romano A; Ragnotti G
    Chem Biol Interact; 1984 Jun; 50(1):77-86. PubMed ID: 6203657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305.
    Presta M; Legati F; Chiesa R; Dell'Era P; Ragnotti G
    Carcinogenesis; 1990 Feb; 11(2):261-5. PubMed ID: 1967984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver tumors induced by a new beta-adrenoreceptor blocking agent in female rats.
    Ragnotti G; Presta M; Riboni L; Zavanella T
    J Natl Cancer Inst; 1982 Apr; 68(4):669-72. PubMed ID: 6121925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition in vitro of yeast DNA polymerase I activity by beta-blockers.
    Presta M; Riboni L; Ragnotti G
    Biosci Rep; 1982 Jan; 2(1):55-62. PubMed ID: 6120725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid and chemical hepatocarcinogenesis: further insights from the hepatocarcinogen ZAMI 1305.
    Presta M; Zavanella T; Mazzocchi C; Ziliani S; Mazzoleni G; Calovini D; Braga M; Ragnotti G
    Toxicol Pathol; 1984; 12(1):49-55. PubMed ID: 6494734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on the tumor-initiating activity of the beta-blocker DL-ZAMI 1305.
    Pacces N; Braga M; Zavanella T; Presta M; Ragnotti G
    Toxicol Pathol; 1986; 14(4):470-6. PubMed ID: 2880384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early liver alterations induced by the sex-dependent hepatocarcinogen beta-blocker ZAMI 1305.
    Presta M; Mazzocchi C; Ziliani S; Zavanella T; Ragnotti G
    Chem Biol Interact; 1984 Dec; 52(2):203-12. PubMed ID: 6150768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305.
    Ragnotti G; Presta M; Maier JA; Rusnati M; Mazzoleni G; Legati F; Chiesa R; Braga M; Calovini D
    Cancer Lett; 1987 Sep; 36(3):253-61. PubMed ID: 3652027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-initiating activity of the beta-blocker ZAMI 1305 in the liver of the female Wistar rat.
    Zavanella T; Presta M; Braga G; Dimito E; Mazzocchi C; Ziliani S; Ragnotti G
    Cancer Lett; 1984 Nov; 25(1):1-11. PubMed ID: 6151420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid modifications in male and female rats treated with the hepatocarcinogen beta-blocker ZAMI 1305.
    Zavanella T; Presta M; Ragnotti G
    Cancer Lett; 1983 Jul; 19(3):293-9. PubMed ID: 6136321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver genotoxic activity of an epoxide derivative of the hepatocarcinogenic beta-blocker DL-ZAMI 1305.
    Presta M; Chiesa R; Legati F; Ginelli B; Tenca S; Ragnotti G
    Cancer Lett; 1990 Nov; 55(1):61-6. PubMed ID: 2245411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver.
    Ziliani S; Presta M; Mazzocchi C; Mazzoleni G; Calovini D; Ragnotti G
    Cancer Lett; 1984 Jul; 23(3):245-51. PubMed ID: 6744248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence on cell-cell communication (dye-transfer) of the oncogenic beta-blocker DL-ZAMI 1305: possible relation to tumor promotion.
    Mazzoleni G; Ragnotti G; Enomoto T; Yamasaki H
    Carcinogenesis; 1985 Oct; 6(10):1477-82. PubMed ID: 2864144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of ionophore A23187 and verapamil on RNA and DNA polymerase activity in rat liver nuclei].
    Kapralov AA
    Ukr Biokhim Zh (1978); 1997; 69(4):25-9. PubMed ID: 9583118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of rat liver RNA polymerases by action of the methylating agents dimethylnitrosamine in vivo and methyl methanesulfonate in vitro.
    Herzog J; Farber JL
    Cancer Res; 1976 May; 36(5):1761-70. PubMed ID: 178432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
    Shulkin BL; Peele ME; Utiger RD
    Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the adverse effects of drugs at the cellular and subcellular levels].
    Nosál' R; Drábiková K; Pecivová J; Ondrias K; Jakubovský J
    Cesk Farm; 1990 May; 39(3):118-21. PubMed ID: 1698127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of benzo[a]pyrene on DNA synthesis and DNA polymerase activity of rat liver nuclei.
    Salazar I; Tarragó-Litvak L; Litvak S; Gil L
    Biochem Pharmacol; 1985 Mar; 34(6):755-62. PubMed ID: 3977952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.